According to Twist Bioscience 's latest financial reports the company's current EPS (TTM) is -$3.70. In 2022 the company made an earnings per share (EPS) of -$3.86 a decrease over its 2021 EPS that were of -$3.35.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.70 | -4.15% |
2022 | -$3.86 | 15.22% |
2021 | -$3.35 | 20.5% |
2020 | -$2.78 | -38.22% |
2019 | -$4.50 | 19.65% |
2018 | -$3.76 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$2.06 | -44.32% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$6.20 | 67.57% | ๐ฌ๐ง UK |
Novavax NVAX | -$7.19 | 94.32% | ๐บ๐ธ USA |
Novocure
NVCR | -$1.86 | -49.73% | Jersey |